Short Interest in Pulmatrix, Inc. (NASDAQ:PULM) Increases By 27.8%

Pulmatrix, Inc. (NASDAQ:PULM) was the target of a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 74,900 shares, a growth of 27.8% from the November 30th total of 58,600 shares. Based on an average trading volume of 453,600 shares, the short-interest ratio is currently 0.2 days. Approximately 2.1% of the shares of the company are sold short.

Wall Street Analyst Weigh In

Separately, StockNews.com started coverage on shares of Pulmatrix in a research report on Saturday. They set a “hold” rating for the company.

Pulmatrix Stock Up 1.7 %

PULM traded up $0.12 during midday trading on Tuesday, reaching $6.98. The company had a trading volume of 31,095 shares, compared to its average volume of 127,981. The business has a 50-day moving average of $4.78 and a two-hundred day moving average of $3.03. Pulmatrix has a 1 year low of $1.55 and a 1 year high of $8.44. The company has a market cap of $25.49 million, a P/E ratio of -2.64 and a beta of 1.53.

Pulmatrix Company Profile

Pulmatrix, Inc, a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.